Broadwood Partners reported a 23.1% stake in Lineage Cell Therapeutics LCTX · 57,848,357 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 23.1%
Last report: 24.5% · filed 25/01/28
Shares held: 57,848,357 sh
Class: Common shares
Stock: Lineage Cell Therapeutics LCTX
Holder: Broadwood Partners
Event date: 25/11/12
Filed: 25/11/14

23.1% stake · −1.4pp from the last report

Stake: 23.1%
Last report: 24.5%
Since last report: −1.4pp

Lineage Cell Therapeutics trades, last 26 weeks

What else happened in Lineage Cell Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/13~25/12/12

Broadwood Partners's other 5% stake reports

Broadwood Partners
5% stakeInsight Molecular Diagnostics
5% stake
Insight Molecular Diagnostics
IMDX
39.7% stake
12,835,134 sh
39.7% stake
Filed 04/27
Broadwood Partners
5% stakeStaar Surgical
5% stake
Staar Surgical
STAA
32.6% stake
16,149,742 sh
32.6% stake
Filed 03/13
Broadwood Partners
5% stakeInsight Molecular Diagnostics
5% stake
Insight Molecular Diagnostics
IMDX
37.4% stake
12,082,089 sh
37.4% stake
Filed 02/12
Broadwood Partners
5% stakeStaar Surgical
5% stake
Staar Surgical
STAA
31.1% stake
15,479,529 sh
31.1% stake
Filed 01/16
Broadwood Partners
5% stakeStaar Surgical
5% stake
Staar Surgical
STAA
30.2% stake
15,045,391 sh
30.2% stake
Filed 25/12/17